share_log

American Oncology Network Announces Attendance and Participation at Leading Community Oncology Conference

American Oncology Network Announces Attendance and Participation at Leading Community Oncology Conference

美国肿瘤学网络宣布出席和参与领先的社区肿瘤学会议
GlobeNewswire ·  03/28 20:00

AON will attend the 2024 Community Oncology Conference as an exhibitor, and its leaders will serve as panelists in various educational sessions.

怡安将作为参展商参加2024年社区肿瘤学会议,其领导人将作为小组成员参加各种教育会议。

American Oncology Network Announces Attendance and Participation at Leading Community Oncology Conference

美国肿瘤学网络宣布出席和参与领先的社区肿瘤学会议

From left to right: Stephen "Fred" Divers, MD, AON's chief medical officer; James Gilmore, PharmD, AON's chief pharmacy & clinical services officer; Mark Moch, AON's chief information officer; Martin Palmeri, MD, Messino Cancer Center's medical oncologist; Alti Rahman, MHA/MBA, CSSBB, AON's chief strategy & innovation officer; and Jan Smithson, Genesis Cancer and Blood Institute's regional physician liaison manager.
从左至右:怡安首席医学官斯蒂芬· “弗雷德” · 迪弗斯医学博士;怡安首席药房和临床服务官詹姆斯·吉尔摩;怡安首席信息官马克·莫赫;梅西诺癌症中心肿瘤内科医生马丁·帕尔梅里;怡安首席战略与创新官CSSBB MHA/MBA Alti Rahman;创世纪癌症首席战略与创新官扬·史密森以及血液研究所的区域医生联络经理。

FORT MYERS, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (Nasdaq: AONC) announced its attendance and panel participation at the annual Community Oncology Alliance (COA) conference from April 4 to April 5 in Orlando, Florida, to further its mission of closing the cancer care gap and ensuring the viability of community oncology.

佛罗里达州迈尔斯堡,2024年3月28日(GLOBE NEWSWIRE)——美国肿瘤网络(AON)(纳斯达克股票代码:AONC)宣布出席4月4日至4月5日在佛罗里达州奥兰多举行的年度社区肿瘤联盟(COA)会议并进行小组讨论,以进一步履行其缩小癌症护理差距和确保社区肿瘤学可行性的使命。

"At AON, we are passionate about supporting the medical practices that reside in our hometowns because of the immense benefits they bring patients," said Stephen "Fred" Divers, MD, AON's chief medical officer, medical oncologist at Genesis Cancer and Blood Institute and co-chair of the COA conference. "We are embracing the conference's theme of 'Stronger Together' and believe in the power of collaboration to improve clinical and patient outcomes, ensuring that there is a healthier future for cancer patients across the nation. I look forward to witnessing our leaders who will take the stage as panelists to share insights that we hope will resonate and guide our fellow colleagues in the industry."

怡安首席医学官、创世纪癌血研究所肿瘤科医生、COA会议联席主席Stephen “Fred” Divers医学博士说:“在怡安,我们热衷于支持家乡的医疗机构,因为它们为患者带来了巨大的好处。”“我们拥护会议的主题,即'团结起来更强大 ',并相信合作能够改善临床和患者预后,确保全国癌症患者拥有更健康的未来。我期待见证我们的领导者以小组成员的身份登台分享见解,我们希望这些见解能够引起共鸣并指导我们的业内同事。”

AON leaders invited to speak at the conference include the following individuals:

受邀在会议上发言的怡安领导人包括以下个人:

  • Jim Chen, MD, an AON consultant and incoming physician, is a panelist in the session "Is AI Ready for Prime Time for Cancer Care."
  • Stephen "Fred" Divers, MD, is a panelist in the sessions "Welcome From the Co-Chairs," "Defining Value in Oncology: Executing VBC Accurately & Ethically to Account for All Stakeholders," "Reflections From the Co-Chairs" and "Meeting Observations From the Co-Chairs."
  • James Gilmore, PharmD, AON's chief pharmacy and clinical services officer, is a panelist in the session "Managing Formularies: Successfully Navigating Multiple Formularies to Balance Clinical & Financial Outcomes."
  • Mark Moch, AON's chief information officer, is a panelist in the session "Preparing for Precision Medicine 2.0 in Community Oncology."
  • Martin Palmeri, MD, MBA, medical oncologist at Messino Cancer Centers, is a panelist in the session "Hospitals: Friend or Foe? Examining Independent Practice-Hospital Relationships & Trends."
  • Alti Rahman, MHA/MBA, CSSBB, AON's chief strategy and innovation officer, is a panelist in the sessions "Welcome From the Co-Chairs," "Guardians of Confidentiality: Navigating Cybersecurity & Data Privacy in Oncology," "Is AI Ready for Prime Time for Cancer Care," "Reflections From the Co-Chairs" and "Meeting Observations From the Co-Chairs."
  • Jan Smithson, regional physician liaison manager for Genesis Cancer and Blood Institute, is a panelist in the session "Marketing Matters: Driving Provider Referrals in Competitive Marketplaces."
  • 怡安顾问、即将上任的医生Jim Chen医学博士是 “人工智能为癌症护理的黄金时段做好准备了吗” 的小组成员。
  • Stephen “Fred” Divers,医学博士,是 “联席主席的欢迎”、“定义肿瘤学的价值:以准确和合乎道德的方式执行VBC以考虑所有利益相关者”、“联合主席的反思” 和 “联合主席的会议观察” 等会议的小组成员。
  • 怡安首席药房和临床服务官PharmD詹姆斯·吉尔摩是 “管理处方组:成功浏览多个处方以平衡临床和财务成果” 会议的小组成员。
  • 怡安首席信息官马克·莫赫是 “为社区肿瘤学中的精准医疗2.0做准备” 会议的小组成员。
  • 梅西诺癌症中心肿瘤内科医生、医学博士、工商管理硕士马丁·帕尔梅里是 “医院:朋友还是敌人?” 会议的小组成员研究独立诊所与医院的关系和趋势。”
  • Alti Rahman,硕士/工商管理硕士,CSSBB,怡安首席战略和创新官,是以下会议的小组成员:“联席主席的欢迎”、“保密守护者:探索肿瘤学领域的网络安全和数据隐私”、“人工智能是否为癌症护理的黄金时段做好了准备”、“联合主席的反思” 和 “会议联合主席的观察”。
  • 创世纪癌症与血液研究所区域医生联络经理扬·史密森是 “营销事务:在竞争激烈的市场中推动提供商转诊” 会议的小组成员。

AON is a fellow leader in the community oncology sector and dedicated to paving the way for independent practices to thrive independently with its support and resources, generating new revenue streams and growth in locations and patient services. Since its inception, AON has provided administrative support and access to critical offerings such as the in-house pharmacy and laboratory services to independent oncology medical practices.

怡安是社区肿瘤学领域的领导者,致力于通过其支持和资源为独立诊所的独立发展铺平道路,创造新的收入来源,促进地点和患者服务的增长。自成立以来,怡安一直为独立肿瘤学医疗机构提供行政支持和关键服务,例如内部药房和实验室服务。

Through the partnership with AON, physicians have the resources needed to focus on providing the highest standard of care to every patient while continuing to deliver comprehensive cancer care, therapies and expanded patient services in their clinics, reducing the reliance on larger health systems and other third-party companies.

通过与怡安的合作,医生拥有所需的资源,可以集中精力为每位患者提供最高标准的护理,同时继续在诊所提供全面的癌症护理、疗法和扩大患者服务,从而减少对大型医疗系统和其他第三方公司的依赖。

"AON and COA share similar missions, which creates a strong foundation for impact in the community oncology industry, and we are excited to be involved in the COA conference this year," said Rahman, AON's chief strategy and innovation officer who also serves as co-chair of the COA conference. "In any sector of healthcare, the sharing of information, knowledge and best practices is important to achieving the necessary advancements in medicine. The conference brings together today's healthcare and community oncology leaders for two days of education and networking. We understand the future of healthcare is a collective effort, and the conference provides a platform to foster unity and the exchange of information. At AON, we strive to be more than event attendees and seek to be catalysts for community oncology."

怡安首席战略和创新官、同时担任COA会议联席主席的拉赫曼说:“怡安和COA有着相似的使命,这为社区肿瘤行业的影响奠定了坚实的基础,我们很高兴能参与今年的COA会议。”“在任何医疗保健领域,信息、知识和最佳实践的共享对于实现医学的必要进步都很重要。该会议汇集了当今的医疗保健和社区肿瘤学领袖,进行了为期两天的教育和交流。我们知道医疗保健的未来是一项集体努力,该会议为促进团结和信息交流提供了一个平台。在怡安,我们努力成为不仅仅是活动的参与者,而是寻求成为社区肿瘤学的催化剂。”

AON is an exhibitor at the conference and can be found at booth 305.

怡安是本次大会的参展商,可在305号展位找到。

For more information about AON, visit .

有关 AON 的更多信息,请访问。

###

###

About American Oncology Network

关于美国肿瘤网络

American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON's rapidly expanding network represents more than 220 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at .

美国肿瘤学网络(AON)(纳斯达克股票代码:AONC)是一个由医生和经验丰富的医疗保健领导者组成的联盟,旨在确保社区肿瘤学和其他专业的长期成功和可行性。怡安成立于2018年,其快速扩张的网络代表着在20个州开展业务的220多家提供商。怡安通过其以医生为主导的模式开创了创新的医疗保健解决方案,促进了基于价值的护理,改善了患者的预后,同时降低了成本并扩大了获得优质护理的机会。怡安为其网络医生提供独立成长所需的工具,同时提供全面的支持、收入多元化的综合辅助服务和执业管理专业知识,使医生能够专注于最重要的事情——为每位患者提供最高标准的护理。怡安致力于通过解决癌症治疗中的差异并确保所有患者都能获得实现最佳健康结果所需的护理来促进健康公平。怡安专注于创新与合作,正在塑造社区肿瘤学的未来。要了解更多信息,请访问。

Attachment

附件

  • American Oncology Network Announces Attendance and Participation at Leading Community Oncology Conference
  • 美国肿瘤学网络宣布出席和参与领先的社区肿瘤学会议
CONTACT: Caroline Hewitt American Oncology Network 941.224.8736 Caroline.Hewitt@AONcology.com 
联系人:Caroline Hewitt 美国肿瘤学网络 941.224.8736 Caroline.Hewitt@AONcology.com 

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发